a statistical trendP < 0.1
Three other monotherapies (STR, IMI, and DOR) and the CEF+DOR combination showed a statistical trend ( P < 0.1) toward lower relative growth rates ( supplementary table S3 , Supplementary Material online), possibly indicating that some monotherapies more often lead to an evolutionary trade-off than drug combinations.